Share on Twitter A statement by the National Health Regulatory Authority on Sunday did not specify which vaccine of two being developed by Sinopharm had been given approval, but cited data from Phase 3 clinical trials that showed an 86% efficacy rate and said Bahrain had participated.…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.